Oncology services provider US Oncology, which was taken private in August, reported a third-quarter 2004 loss of $13.6 million on $588.7 million in revenues, compared with net income of $17.9 million for the third quarter of 2003 on revenues of $509.1 million, the company reported today.
Excluding merger-related charges and the loss on the early retirement of debt and the sale of assets, the company reported third-quarter net income of $18.2 million.
For the nine months ending Sept. 30, the company reported revenues of $1.679 billion and net income of $31.1 million with merger-related charges, $62.9 million excluding those charges.
US Oncology, based in Houston, whose stock formerly was traded on the NASDAQ exchange, accepted a $1.7 billion offer in March from US Oncology Holdings, owned by Welsh, Carson, Anderson & Stowe, one of the largest U.S. private equity firms, which had owned a 14.5% stake in company.
The specialty physician practice management company reports it now serves 940 affiliated physicians at more than 500 sites, including 82 integrated cancer centers, in 32 states.